Retatrutide
Triple agonist hitting the GIP, GLP-1 and glucagon receptors. The newest name in incretin research.
HELLOVAN takes 10% off.Free tracked shipping over $175Prices are per vial in CAD before tax. Pick a 3-pack or 6-pack on any product page to save 8% or 15%.
Triple agonist hitting the GIP, GLP-1 and glucagon receptors. The newest name in incretin research.
Dual GIP / GLP-1 receptor agonist. A workhorse compound for incretin and metabolic study designs.
GLP-1 receptor agonist with a fatty-acid side chain for albumin binding. The common reference compound.
Long-acting amylin analogue, often studied next to GLP-1 agonists in combination designs.
hGH fragment 177–191 with an added tyrosine. Studied in adipocyte and lipolysis models.
Small molecule, not a peptide. Inhibits NNMT and shows up in NAD+ salvage and adipocyte research.
15-amino-acid sequence taken from a gastric protein. A staple of tissue-repair and angiogenesis models.
Synthetic version of thymosin beta-4's actin-binding region. Studied in cell migration and wound models.
TB-500 and BPC-157, 5 mg each, co-lyophilized in one vial for paired designs.
Lys-Pro-Val, the tail end of alpha-MSH. Studied in inflammatory signalling.
Acetylated 28-mer from the thymus, studied in immune-modulation pathways.
Modified GRF (1–29) without the DAC tail, so a short half-life. Studied at the GHRH receptor.
Selective ghrelin-receptor agonist, five residues long. A go-to in secretagogue research.
CJC-1295 (no DAC) and ipamorelin, 5 mg each, in one vial for GHRH-plus-ghrelin designs.
Full-length GHRH (1–44) analogue stabilized with a trans-3-hexenoyl group.
GHRH (1–29) amide, the shortest fully active GHRH fragment.
ACTH (4–10) analogue with a Pro-Gly-Pro tail. Studied for BDNF and neurotrophic signalling.
Tuftsin analogue, seven residues. Studied in anxiolytic and immune-signalling models.
Selank and Semax, 10 mg each, co-lyophilized for paired neuro designs.
Delta sleep-inducing peptide, nine residues. Studied in sleep-regulation and stress models.
Bremelanotide, a cyclic melanocortin agonist at MC3R and MC4R. Used in receptor pharmacology.
Cyclic alpha-MSH analogue studied at melanocortin receptors and in pigmentation pathways.
The nine-residue hormone itself. A reference ligand for oxytocin-receptor work.
Glu-Asp-Arg tripeptide from the short bioregulator family.
Copper tripeptide (Gly-His-Lys:Cu). Studied in dermal matrix and wound models. The powder is blue.
Acetyl octapeptide-3, studied for SNARE-complex interference in cosmetic science.
GHK-Cu, BPC-157 and TB-500 in one 70 mg vial for skin and recovery designs.
The GLOW trio plus KPV, 80 mg total, for designs that add inflammatory signalling.
16-residue peptide encoded in mitochondrial DNA. Studied in metabolic homeostasis and exercise models.
Nicotinamide adenine dinucleotide, the cell's main redox coenzyme.
Elamipretide, a tetrapeptide that targets cardiolipin on the inner mitochondrial membrane.
Ala-Glu-Asp-Gly. Studied in telomerase expression and circadian models.
Thymic polypeptide fraction from the bioregulator family.
The active 10-residue end of kisspeptin, ligand of KISS1R and a key reproductive-axis tool.
30 mL multi-dose sterile water with 0.9% benzyl alcohol, for reconstituting lyophilized peptides.